Combination therapy using tafamidis and neurohormonal blockers for cardiac amyloidosis and a reduced ejection fraction: a case report

Cardiac amyloidosis usually presents with diastolic dysfunction, but sometimes systolic dysfunction develops, particularly at its advanced stage. However, the therapeutic strategy for patients with cardiac amyloidosis and systolic dysfunction remains unknown. We report a 77-year-old man who was diag...

Descripción completa

Detalles Bibliográficos
Autores principales: Imamura, Teruhiko, Izumida, Toshihide, Hori, Masakazu, Tanaka, Shuhei, Kinugawa, Koichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340939/
https://www.ncbi.nlm.nih.gov/pubmed/35904051
http://dx.doi.org/10.1177/03000605221078484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340939/
https://www.ncbi.nlm.nih.gov/pubmed/35904051
http://dx.doi.org/10.1177/03000605221078484

Ejemplares similares